Plus Therapeutics reported $4.26M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Baxter International USD 735M 7M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
Northwest Biotherapeutics USD 6.54M 534K Mar/2026
Plus Therapeutics USD 4.26M 779K Mar/2026
Sanofi EUR 2.63B 307M Jun/2026
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.03B 34M Jun/2026